Skip to search formSkip to main contentSkip to account menu

prizidilol

Known as: 3(2H)-Pyridazinone, 6-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-, Hydrazone, 3(2H)-Pyridazinone, 6-(2-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)phenyl)-, hydrazone, dihydrochloride, (+-)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The metal complexing properties of two antihypertensive drugs, hydralazine (1-hydrazinophthalazine) and prizidilol (a… 
Review
1988
Review
1988
The cardinal hemodynamic disturbance in established essential hypertension is an increased total peripheral resistance… 
1986
1986
Prizidilol (SK&F 92657-A2), an anti-hypertensive agent, has undergone a range of prescribed toxicity studies required for the… 
1984
1984
Effective renal plasma flow and glomerular filtration rate were measured in 22 mild-to-moderate, uncomplicated, essential… 
1983
1983
1 The effects of a single oral dose of 600 mg of prizidilol on renal function were studied 5 to 6 h after dosing in six normal… 
1982
1982
We studied the long-term hemodynamic effect of prizidilol (a precapillary vasodilator and β-adrenoceptor blocker) in 14 men aged… 
1982
1982
Summary Several new β-adrenoceptor antagonists (sulfinalol, MK 761, and prizidilol) have been reported to possess direct… 
1981
1981
1. The antihypertensive effect of 4 weeks' treatment with prizidilol (SKF 92657) (mean dosage 520 mg once or twice daily) was… 
1981
1981
1. Prizidilol (SKF 92 657), a new antihypertensive drug with combined precapillary vasodilator and non-selective β-adrenoceptor… 
1981
1981
1. Prizidilol (SKF 92657), a new antihypertensive drug with combined precapillary vasodilator and non-selective beta-adrenoceptor…